Advanced search
Publication Cover
Bioengineered Volume 11, 2020 - Issue 1
Submit an article Journal homepage
1,599
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Serum miR-125b levels associated with epithelial ovarian cancer (EOC) development and treatment responses

Zhonghua Chena Department of Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China;b Department of Obstetrics and Gynecology II, People’s Hospital of Gaotang County, Liaocheng, Shandong, China
,
Xiaoli Guoc Department of Reproductive Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
,
Shukai Sund Department of Clinical Lab, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
,
Caixia Lua Department of Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
&
Liming Wanga Department of Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, ChinaCorrespondence[email protected]
Pages 311-317 | Received 29 Jan 2020, Accepted 24 Feb 2020, Published online: 04 Mar 2020

References

  • Xian W, George S. Meeting report from the 2018 12th biennial ovarian cancer research symposium detection and prevention of ovarian cancer. Int J Gynecol Cancer. 2019;29(Suppl 2):s2–s6.
  • Bast RC Jr, Hennessy B, Mills GB. The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer. 2009;9:415–428.
  • Vogell A, Evans ML. Cancer screening in women. Obstet Gynecol Clin North Am. 2019;46:485–499.
  • Park JH, Jeong GH, Lee KS, et al. Genetic variations in MicroRNA genes and cancer risk: a field synopsis and meta-analysis. Eur J Clin Invest. 2020;26:e13203.
  • Zhao C, Zhang Y, Popel AS. Mechanistic computational models of microRNA-mediated signaling networks in human diseases. Int J Mol Sci. 2019;20:E421.
  • Noruzi S, Azizian M, Mohammadi R, et al. Micro-RNAs as critical regulators of matrix metalloproteinases in cancer. J Cell Biochem. 2018;119:8694–8712.
  • Ghafouri-Fard S, Shoorei H, Taheri M. miRNA profile in ovarian cancer. Exp Mol Pathol. 2020;113:104381.
  • Almeida MI, Reis RM, Calin GA. MicroRNA history: discovery, recent applications, and next frontiers. Mutat Res. 2011;717:1–8.
  • Cretoiu D, Xu J, Xiao J, et al. Circulating microRNAs as potential molecular biomarkers in pathophysiological evolution of pregnancy. Dis Markers. 2016;2016:3851054.
  • Vaksman O, Tropé C, Davidson B, et al. Exosome-derived miRNAs and ovarian carcinoma progression. Carcinogenesis. 2014;35:2113–2120.
  • Tokuhisa M, Ichikawa Y, Kosaka N, et al. Exosomal miRNAs from peritoneum lavage fluid as potential prognostic biomarkers of peritoneal metastasis in gastric cancer. PLoS One. 2015;10:e0130472.
  • Xie Z, Yin X, Gong B, et al. Salivary microRNAs show potential as a noninvasive biomarker for detecting resectable pancreatic cancer. Cancer Prev Res (Phila). 2015;8:165–173.
  • Harrandah AM, Mora RA, Chan EKL. Emerging microRNAs in cancer diagnosis, progression, and immune surveillance. Cancer Lett. 2018;438:126–132.
  • Wang JK, Wang Z, Li G. MicroRNA-125 in immunity and cancer. Cancer Lett. 2019;454:134–144.
  • Ying X, Wei K, Lin Z, et al. MicroRNA-125b suppresses ovarian cancer progression via suppression of the epithelial-mesenchymal transition pathway by targeting the SET protein. Cell Physiol Biochem. 2016;39:501–510.
  • Guan Y, Yao H, Zheng Z, et al. MiR-125b targets BCL3 and suppresses ovarian cancer proliferation. Int J Cancer. 2011;128:2274–2283.
  • Zuberi M, Khan I, Mir R, et al. Utility of serum miR-125b as a diagnostic and prognostic indicator and its alliance with a panel of tumor suppressor genes in epithelial ovarian cancer. PLoS One. 2016;11:e0153902.
  • Gloss BS, Samimi G. Epigenetic biomarkers in epithelial ovarian cancer. Cancer Lett. 2014;342:257–263.
  • Jiang Y, Luan Y, Chang H, et al. The diagnostic and prognostic value of serum microRNA-125b-5p in patients with multiple myeloma. Oncol Lett. 2018;16:4001–4007.
  • Kassem NM, Makar WS, Kassem HA, et al. Circulating miR-34a and miR-125b as promising non invasive biomarkers in Egyptian locally advanced breast cancer patients. Asian Pac J Cancer Prev. 2019;20:2749–2755.
  • Yagi T, Iinuma H, Hayama T, et al. Serum exosomal microRNA-125b as a monitoring biomarker of resistance to mFOLFOX6-based chemotherapy in advanced and recurrent colorectal cancer patients. Mol Clin Oncol. 2019;11:416–424.
  • Gadducci A, Sergiampietri C, Lanfredini N, et al. Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research. Gynecol Endocrinol. 2014;30:266–271.
  • He J, Xu Q, Jing Y, et al. Reactive oxygen species regulate ERBB2 and ERBB3 expression via miR-199a/125b and DNA methylation. EMBO Rep. 2012;13:1116–1122.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.